Bernie Marcus Foundation Donates $28.7M to Stem Cell Heart Attack Trials
Source: Fortune. Casualplayhub News adds summary, context, and editorial framing while linking back to the original report.
Ad eligibility review: sensitive-topic
Before Bernie Marcus co-founded the home improvement giant Home Depot, which now boasts a market value of $343 billion, he harbored a different ambition: to become a doctor. That dream was derailed when his family could not afford medical school, prompting him to enroll in pharmacy school at Rutgers University. Even then, Marcus often skipped classes to sell Amana freezers door-to-door, as recounted in a Home Depot-published memoir, but he still earned his degree. After graduating, he climbed the corporate ladder at various manufacturing firms until a pivotal moment in 1978: he was fired from a now-defunct hardware store called Handy Dan. That setback spurred him to reinvent himself, and he co-founded Home Depot alongside Arthur Blank. Marcus died in November 2024 at age 95, with an estimated net worth of $11 billion.
Now, his philanthropic legacy is paying tribute to his original passion for medicine. The Marcus Foundation, which Bernie and his wife Billi established in 1989, has awarded $28.7 million to Dr. Chuck Murry, director of the University of Southern California's Stem Cell Center. The funds will support clinical trials exploring stem cell-based therapies designed to regenerate tissue damaged by heart attacks. "Murry and his team have advanced gene-edited cellular therapy to the point that the time is right to support cells as living medicine in this new form of treatment," said Jonathan Simons, chief science officer of the Marcus Foundation, in a statement.
This gift represents the largest single donation the foundation has ever made to USC and one of its most significant contributions to academic medicine. It follows a pattern of targeted giving. In 2024, the foundation donated $25.9 million for stroke research at Emory University School of Medicine and Grady Health System's Marcus Stroke and Neuroscience Center. In 2019, it gave $20 million to establish a Department of Integrative Medicine and Nutritional Sciences at Jefferson's Sidney Kimmel Medical College.
Since its founding, the Marcus Foundation has granted more than $2.7 billion through over 3,500 grants, covering medical research, Jewish causes, free enterprise, veterans, and children's welfare. Medicine has always been a central focus. The foundation describes itself as a leading U.S. philanthropist in biomedical research, concentrating on five key areas: stem cell research and regenerative medicine, earlier cancer detection and treatment, autism diagnosis and treatment, integrative medicine, and cardiovascular disease—including stroke.
The foundation's first grant, roughly $110,000, went to Emory's Egleston Children's Research. Marcus also provided initial funding to launch Autism Speaks in 2005 and built the Marcus Stroke and Neuroscience Center at Grady, the Marcus Autism Center at Children's Healthcare of Atlanta, and the Marcus Institute for Brain Health at the University of Colorado Anschutz Medical Campus, which treats veterans and retired athletes with traumatic brain injuries.
His giving was deliberate. "We decided to narrow the field to those things that I was really, truly interested in," Marcus told Philanthropy Roundtable in 2012, describing his shift away from what he called a "buckshot approach." Trustee Mike Leven added, "People may not understand how hard it is to do this. People are coming at you all the time, good people with good causes. Unless you discipline yourself, you're going to overgive and underachieve. Bernie's better at it than anybody I know."
Article commentary
The Marcus Foundation's $28.7 million gift to USC for stem cell heart attack research is a powerful testament to how a billionaire's unfulfilled childhood dream can shape a philanthropic legacy. Bernie Marcus, who never became a doctor, redirected his immense wealth toward medical breakthroughs that could save millions of lives. This donation is not an isolated act of generosity but part of a deliberate, disciplined strategy that has seen the foundation pour over $2.7 billion into causes that align with Marcus's personal passions. What stands out is the foundation's focus on high-risk, high-reward biomedical research. Stem cell therapy for heart attack damage is still in experimental stages, but it holds transformative potential. By funding Dr. Chuck Murry's clinical trials, the Marcus Foundation is betting on regenerative medicine—a field that could dramatically change how we treat heart disease, the leading cause of death globally. This approach mirrors a broader trend among top philanthropists, such as the Chan Zuckerberg Initiative or the Gates Foundation, who increasingly target scientific frontiers rather than traditional charity. However, the Marcus Foundation's method is notably different. Rather than spreading money thinly across many causes, Marcus honed in on five areas: stem cell research, cancer detection, autism, integrative medicine, and cardiovascular disease. This focus, as he said, avoids the "buckshot approach" and ensures that each dollar has maximum impact. Trustee Mike Leven's comment about "overgiving and underachieving" underscores the discipline required to maintain such a strategy. In a world where nonprofits compete for attention, the ability to say no is as important as the ability to give. Critically, this donation also highlights the importance of academic partnerships. USC's Stem Cell Center is one of the leading institutions in the field, and the Marcus Foundation's backing provides not just funding but also legitimacy. For a researcher like Dr. Murry, such support can accelerate the timeline from lab to clinic. The foundation's track record with earlier gifts—like the $25.9 million for stroke research at Emory—shows a pattern of sustained, strategic investment in specific institutions, creating long-term research ecosystems. Yet, the commentary must also consider the broader context of billionaire philanthropy. Critics argue that such large private donations can skew public research priorities, potentially sidelining less glamorous but equally important areas. The Marcus Foundation's focus on stem cell therapy, cancer, and cardiovascular disease reflects the interests of a wealthy individual, not necessarily the most pressing needs of society. Furthermore, the tax benefits of charitable foundations mean that billions of dollars that could have gone to the government as inheritance taxes are instead directed by private foundations, raising questions about democratic accountability. Nevertheless, the Marcus Foundation's impact is undeniable. It has helped establish major medical centers, supported autism advocacy, and funded cutting-edge research. The $28.7 million gift to USC is a continuation of that legacy. For Bernie Marcus, who rose from a pharmacy student selling freezers to a billionaire retailer, this donation is a fitting way to honor his unfulfilled medical dream. It may not make him a doctor, but it could help mend hearts—literally and figuratively.